Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Synthetic hypericin

EU orphan designation number: EU/3/15/1515   
Active ingredient: Synthetic hypericin
Indication: Treatment of cutaneous T-cell lymphoma
Sponsor: Kinesys Consulting Ltd
20 -23 Woodside Place, Glasgow G3 7QF, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/07/2015 Orphan designation EMA/OD/033/15 (2015)5421 of 28/07/2015